0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Phage Therapy Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-31O15967
Home | Market Reports | Science| Biological Sciences
Global and India Phage Therapy Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Phage Therapy Market Report & Forecast 2023-2029

Code: QYRE-Auto-31O15967
Report
December 2023
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Phage Therapy Market Size

The global Phage Therapy revenue was US$ 32 million in 2022 and is forecast to a readjusted size of US$ 100.8 million by 2029 with a CAGR of 17.6% during the review period (2023-2029).

and India Phage Therapy Market

and India Phage Therapy Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
In India, the Phage Therapy revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report focuses on global and India Phage Therapy market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Phage Therapy will continue to grow rapidly in the future.
Global Phage Therapy Scope and Market Size
Phage Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Phage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Phage Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Phage Therapy Market Report

Report Metric Details
Report Name and India Phage Therapy Market
Forecasted market size in 2029 US$ 100.8 million
CAGR 17.6%
Forecasted years 2023 - 2029
Segment by Type
  • DsDNA Bacteriophage
  • SsDNA Bacteriophage
  • SsRNA Bacteriophage
  • Others
Segment by Application
  • Animal Health
  • Aquaculture
  • Agriculture
  • Food Industry
  • Human Health
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Phage Therapy Market size in 2029?

Ans: The and India Phage Therapy Market size in 2029 will be US$ 100.8 million.

What is the market share of major companies in and India Phage Therapy Market?

Ans: The top 3 players occupy about 25% shares of the global market.

What is the and India Phage Therapy Market share by region?

Ans: North America and Europe are main markets, they occupy about 60% of the global market. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the and India Phage Therapy Market share by type?

Ans: DsDNA Bacteriophage is the main type, with a share over 90%.

What is the and India Phage Therapy Market share by application?

Ans: Animal Health is the main application, which holds a share about 55%.

Who are the main players in the and India Phage Therapy Market report?

Ans: The main players in the and India Phage Therapy Market are NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage

What are the Application segmentation covered in the and India Phage Therapy Market report?

Ans: The Applications covered in the and India Phage Therapy Market report are Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others

What are the Type segmentation covered in the and India Phage Therapy Market report?

Ans: The Types covered in the and India Phage Therapy Market report are DsDNA Bacteriophage, SsDNA Bacteriophage, SsRNA Bacteriophage, Others

1 Study Coverage
1.1 Phage Therapy Product Introduction
1.2 Global Phage Therapy Outlook 2018 VS 2022 VS 2029
1.2.1 Global Phage Therapy Market Size for the Year 2018-2029
1.2.2 India Phage Therapy Market Size for the Year 2018-2029
1.3 Phage Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Phage Therapy in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Phage Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Phage Therapy Market Dynamics
1.4.1 Phage Therapy Industry Trends
1.4.2 Phage Therapy Market Drivers
1.4.3 Phage Therapy Market Challenges
1.4.4 Phage Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Phage Therapy by Type
2.1 Phage Therapy Market Segment by Type
2.1.1 DsDNA Bacteriophage
2.1.2 SsDNA Bacteriophage
2.1.3 SsRNA Bacteriophage
2.1.4 Others
2.2 Global Phage Therapy Market Size by Type (2018, 2022 & 2029)
2.3 Global Phage Therapy Market Size by Type (2018-2029)
2.4 India Phage Therapy Market Size by Type (2018, 2022 & 2029)
2.5 India Phage Therapy Market Size by Type (2018-2029)
3 Phage Therapy by Application
3.1 Phage Therapy Market Segment by Application
3.1.1 Animal Health
3.1.2 Aquaculture
3.1.3 Agriculture
3.1.4 Food Industry
3.1.5 Human Health
3.1.6 Others
3.2 Global Phage Therapy Market Size by Application (2018, 2022 & 2029)
3.3 Global Phage Therapy Market Size by Application (2018-2029)
3.4 India Phage Therapy Market Size by Application (2018, 2022 & 2029)
3.5 India Phage Therapy Market Size by Application (2018-2029)
4 Global Phage Therapy Competitor Landscape by Company
4.1 Global Phage Therapy Market Size by Company
4.1.1 Global Key Companies of Phage Therapy, Ranked by Revenue (2022)
4.1.2 Global Phage Therapy Revenue by Player (2018-2023)
4.2 Global Phage Therapy Concentration Ratio (CR)
4.2.1 Phage Therapy Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Phage Therapy in 2022
4.2.3 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Phage Therapy Head office and Area Served
4.4 Global Key Players of Phage Therapy, Product and Application
4.5 Global Key Players of Phage Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Phage Therapy Market Size by Company
4.7.1 Key Players of Phage Therapy in India, Ranked by Revenue (2022)
4.7.2 India Phage Therapy Revenue by Players (2021, 2022 & 2023)
5 Global Phage Therapy Market Size by Region
5.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Phage Therapy Market Size by Region (2018-2029)
5.2.1 Global Phage Therapy Market Size by Region: 2018-2023
5.2.2 Global Phage Therapy Market Size by Region (2024-2029)
6 Americas
6.1 Americas Phage Therapy Market Size YoY Growth 2018-2029
6.2 Americas Phage Therapy Market Size by Type
6.2.1 Americas Phage Therapy Market Size by Type (2018-2023)
6.2.2 Americas Phage Therapy Market Size by Type (2024-2029)
6.2.3 Americas Phage Therapy Market Share by Type (2018-2029)
6.3 Americas Phage Therapy Market Size by Application
6.3.1 Americas Phage Therapy Market Size by Application (2018-2023)
6.3.2 Americas Phage Therapy Market Size by Application (2024-2029)
6.3.3 Americas Phage Therapy Market Share by Application (2018-2029)
6.4 Americas Phage Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Phage Therapy Market Size YoY Growth 2018-2029
7.2 EMEA Phage Therapy Market Size by Type
7.2.1 EMEA Phage Therapy Market Size by Type (2018-2023)
7.2.2 EMEA Phage Therapy Market Size by Type (2024-2029)
7.2.3 EMEA Phage Therapy Market Share by Type (2018-2029)
7.3 EMEA Phage Therapy Market Size by Application
7.3.1 EMEA Phage Therapy Market Size by Application (2018-2023)
7.3.2 EMEA Phage Therapy Market Size by Application (2024-2029)
7.3.3 EMEA Phage Therapy Market Share by Application (2018-2029)
7.4 EMEA Phage Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Phage Therapy Market Size YoY Growth 2018-2029
8.2 China Phage Therapy Market Size by Type
8.2.1 China Phage Therapy Market Size by Type (2018-2023)
8.2.2 China Phage Therapy Market Size by Type (2024-2029)
8.2.3 China Phage Therapy Market Share by Type (2018-2029)
8.3 China Phage Therapy Market Size by Application
8.3.1 China Phage Therapy Market Size by Application (2018-2023)
8.3.2 China Phage Therapy Market Size by Application (2024-2029)
8.3.3 China Phage Therapy Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Phage Therapy Market Size YoY Growth 2018-2029
9.2 APAC Phage Therapy Market Size by Type
9.2.1 APAC Phage Therapy Market Size by Type (2018-2023)
9.2.2 APAC Phage Therapy Market Size by Type (2024-2029)
9.2.3 APAC Phage Therapy Market Share by Type (2018-2029)
9.3 APAC Phage Therapy Market Size by Application
9.3.1 APAC Phage Therapy Market Size by Application (2018-2023)
9.3.2 APAC Phage Therapy Market Size by Application (2024-2029)
9.3.3 APAC Phage Therapy Market Share by Application (2018-2029)
9.4 APAC Phage Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 NPO Microgen
10.1.1 NPO Microgen Company Details
10.1.2 NPO Microgen Business Overview
10.1.3 NPO Microgen Phage Therapy Introduction
10.1.4 NPO Microgen Revenue in Phage Therapy Business (2018-2023)
10.1.5 NPO Microgen Recent Development
10.2 Proteon Pharmaceuticals
10.2.1 Proteon Pharmaceuticals Company Details
10.2.2 Proteon Pharmaceuticals Business Overview
10.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
10.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2018-2023)
10.2.5 Proteon Pharmaceuticals Recent Development
10.3 Phagelux
10.3.1 Phagelux Company Details
10.3.2 Phagelux Business Overview
10.3.3 Phagelux Phage Therapy Introduction
10.3.4 Phagelux Revenue in Phage Therapy Business (2018-2023)
10.3.5 Phagelux Recent Development
10.4 Intralytix
10.4.1 Intralytix Company Details
10.4.2 Intralytix Business Overview
10.4.3 Intralytix Phage Therapy Introduction
10.4.4 Intralytix Revenue in Phage Therapy Business (2018-2023)
10.4.5 Intralytix Recent Development
10.5 Micreos
10.5.1 Micreos Company Details
10.5.2 Micreos Business Overview
10.5.3 Micreos Phage Therapy Introduction
10.5.4 Micreos Revenue in Phage Therapy Business (2018-2023)
10.5.5 Micreos Recent Development
10.6 Eliava BioPreparations
10.6.1 Eliava BioPreparations Company Details
10.6.2 Eliava BioPreparations Business Overview
10.6.3 Eliava BioPreparations Phage Therapy Introduction
10.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2018-2023)
10.6.5 Eliava BioPreparations Recent Development
10.7 Locus Biosciences,Inc
10.7.1 Locus Biosciences,Inc Company Details
10.7.2 Locus Biosciences,Inc Business Overview
10.7.3 Locus Biosciences,Inc Phage Therapy Introduction
10.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2018-2023)
10.7.5 Locus Biosciences,Inc Recent Development
10.8 Pharmex Group,LLC
10.8.1 Pharmex Group,LLC Company Details
10.8.2 Pharmex Group,LLC Business Overview
10.8.3 Pharmex Group,LLC Phage Therapy Introduction
10.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2018-2023)
10.8.5 Pharmex Group,LLC Recent Development
10.9 Pherecydes Pharma
10.9.1 Pherecydes Pharma Company Details
10.9.2 Pherecydes Pharma Business Overview
10.9.3 Pherecydes Pharma Phage Therapy Introduction
10.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2018-2023)
10.9.5 Pherecydes Pharma Recent Development
10.10 APS Biocontrol Ltd. (APS)
10.10.1 APS Biocontrol Ltd. (APS) Company Details
10.10.2 APS Biocontrol Ltd. (APS) Business Overview
10.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
10.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2018-2023)
10.10.5 APS Biocontrol Ltd. (APS) Recent Development
10.11 Qingdao Phagepharm Bio-tech
10.11.1 Qingdao Phagepharm Bio-tech Company Details
10.11.2 Qingdao Phagepharm Bio-tech Business Overview
10.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
10.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2018-2023)
10.11.5 Qingdao Phagepharm Bio-tech Recent Development
10.12 Fixed-Phage Limited
10.12.1 Fixed-Phage Limited Company Details
10.12.2 Fixed-Phage Limited Business Overview
10.12.3 Fixed-Phage Limited Phage Therapy Introduction
10.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2018-2023)
10.12.5 Fixed-Phage Limited Recent Development
10.13 Zeptometrix
10.13.1 Zeptometrix Company Details
10.13.2 Zeptometrix Business Overview
10.13.3 Zeptometrix Phage Therapy Introduction
10.13.4 Zeptometrix Revenue in Phage Therapy Business (2018-2023)
10.13.5 Zeptometrix Recent Development
10.14 Phage International, Inc.
10.14.1 Phage International, Inc. Company Details
10.14.2 Phage International, Inc. Business Overview
10.14.3 Phage International, Inc. Phage Therapy Introduction
10.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2018-2023)
10.14.5 Phage International, Inc. Recent Development
10.15 MicroMir
10.15.1 MicroMir Company Details
10.15.2 MicroMir Business Overview
10.15.3 MicroMir Phage Therapy Introduction
10.15.4 MicroMir Revenue in Phage Therapy Business (2018-2023)
10.15.5 MicroMir Recent Development
10.16 iNtODEWORLD, Inc.
10.16.1 iNtODEWORLD, Inc. Company Details
10.16.2 iNtODEWORLD, Inc. Business Overview
10.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
10.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2018-2023)
10.16.5 iNtODEWORLD, Inc. Recent Development
10.17 NEXTBIOTICS
10.17.1 NEXTBIOTICS Company Details
10.17.2 NEXTBIOTICS Business Overview
10.17.3 NEXTBIOTICS Phage Therapy Introduction
10.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2018-2023)
10.17.5 NEXTBIOTICS Recent Development
10.18 Armata Pharmaceuticals, Inc.
10.18.1 Armata Pharmaceuticals, Inc. Company Details
10.18.2 Armata Pharmaceuticals, Inc. Business Overview
10.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
10.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2018-2023)
10.18.5 Armata Pharmaceuticals, Inc. Recent Development
10.19 Innophage
10.19.1 Innophage Company Details
10.19.2 Innophage Business Overview
10.19.3 Innophage Phage Therapy Introduction
10.19.4 Innophage Revenue in Phage Therapy Business (2018-2023)
10.19.5 Innophage Recent Development
10.20 Adaptive Phage Therapeutics
10.20.1 Adaptive Phage Therapeutics Company Details
10.20.2 Adaptive Phage Therapeutics Business Overview
10.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
10.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2018-2023)
10.20.5 Adaptive Phage Therapeutics Recent Development
10.21 TechnoPhage
10.21.1 TechnoPhage Company Details
10.21.2 TechnoPhage Business Overview
10.21.3 TechnoPhage Phage Therapy Introduction
10.21.4 TechnoPhage Revenue in Phage Therapy Business (2018-2023)
10.21.5 TechnoPhage Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Tables
    Table 1. Phage Therapy Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Phage Therapy Market Trends
    Table 3. Phage Therapy Market Drivers
    Table 4. Phage Therapy Market Challenges
    Table 5. Phage Therapy Market Restraints
    Table 6. Global Phage Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Phage Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Phage Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Phage Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Phage Therapy, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Phage Therapy Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Phage Therapy Revenue Share by Player, 2018-2023
    Table 13. Global Phage Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Phage Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2022)
    Table 15. Global Key Players of Phage Therapy, Headquarters and Area Served
    Table 16. Global Key Players of Phage Therapy, Product and Application
    Table 17. Global Key Players of Phage Therapy, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Phage Therapy in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Phage Therapy Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Phage Therapy Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Phage Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Phage Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Phage Therapy Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Phage Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Phage Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Phage Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Phage Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Phage Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Phage Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Phage Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Phage Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Phage Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Phage Therapy Market Size by Region (2024-2029) & (US$ Million)
    Table 51. NPO Microgen Company Details
    Table 52. NPO Microgen Business Overview
    Table 53. NPO Microgen Phage Therapy Product
    Table 54. NPO Microgen Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 55. NPO Microgen Recent Development
    Table 56. Proteon Pharmaceuticals Company Details
    Table 57. Proteon Pharmaceuticals Business Overview
    Table 58. Proteon Pharmaceuticals Phage Therapy Product
    Table 59. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 60. Proteon Pharmaceuticals Recent Development
    Table 61. Phagelux Company Details
    Table 62. Phagelux Business Overview
    Table 63. Phagelux Phage Therapy Product
    Table 64. Phagelux Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 65. Phagelux Recent Development
    Table 66. Intralytix Company Details
    Table 67. Intralytix Business Overview
    Table 68. Intralytix Phage Therapy Product
    Table 69. Intralytix Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 70. Intralytix Recent Development
    Table 71. Micreos Company Details
    Table 72. Micreos Business Overview
    Table 73. Micreos Phage Therapy Product
    Table 74. Micreos Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 75. Micreos Recent Development
    Table 76. Eliava BioPreparations Company Details
    Table 77. Eliava BioPreparations Business Overview
    Table 78. Eliava BioPreparations Phage Therapy Product
    Table 79. Eliava BioPreparations Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 80. Eliava BioPreparations Recent Development
    Table 81. Locus Biosciences,Inc Company Details
    Table 82. Locus Biosciences,Inc Business Overview
    Table 83. Locus Biosciences,Inc Phage Therapy Product
    Table 84. Locus Biosciences,Inc Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 85. Locus Biosciences,Inc Recent Development
    Table 86. Pharmex Group,LLC Company Details
    Table 87. Pharmex Group,LLC Business Overview
    Table 88. Pharmex Group,LLC Phage Therapy Product
    Table 89. Pharmex Group,LLC Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 90. Pharmex Group,LLC Recent Development
    Table 91. Pherecydes Pharma Company Details
    Table 92. Pherecydes Pharma Business Overview
    Table 93. Pherecydes Pharma Phage Therapy Product
    Table 94. Pherecydes Pharma Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 95. Pherecydes Pharma Recent Development
    Table 96. APS Biocontrol Ltd. (APS) Company Details
    Table 97. APS Biocontrol Ltd. (APS) Business Overview
    Table 98. APS Biocontrol Ltd. (APS) Phage Therapy Product
    Table 99. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 100. APS Biocontrol Ltd. (APS) Recent Development
    Table 101. Qingdao Phagepharm Bio-tech Company Details
    Table 102. Qingdao Phagepharm Bio-tech Business Overview
    Table 103. Qingdao Phagepharm Bio-tech Phage Therapy Product
    Table 104. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 105. Qingdao Phagepharm Bio-tech Recent Development
    Table 106. Fixed-Phage Limited Company Details
    Table 107. Fixed-Phage Limited Business Overview
    Table 108. Fixed-Phage Limited Phage Therapy Product
    Table 109. Fixed-Phage Limited Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 110. Fixed-Phage Limited Recent Development
    Table 111. Zeptometrix Company Details
    Table 112. Zeptometrix Business Overview
    Table 113. Zeptometrix Phage Therapy Product
    Table 114. Zeptometrix Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 115. Zeptometrix Recent Development
    Table 116. Phage International, Inc. Company Details
    Table 117. Phage International, Inc. Business Overview
    Table 118. Phage International, Inc. Phage Therapy Product
    Table 119. Phage International, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 120. Phage International, Inc. Recent Development
    Table 121. MicroMir Company Details
    Table 122. MicroMir Business Overview
    Table 123. MicroMir Phage Therapy Product
    Table 124. MicroMir Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 125. MicroMir Recent Development
    Table 126. iNtODEWORLD, Inc. Company Details
    Table 127. iNtODEWORLD, Inc. Business Overview
    Table 128. iNtODEWORLD, Inc. Phage Therapy Product
    Table 129. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 130. iNtODEWORLD, Inc. Recent Development
    Table 131. NEXTBIOTICS Company Details
    Table 132. NEXTBIOTICS Business Overview
    Table 133. NEXTBIOTICS Phage Therapy Product
    Table 134. NEXTBIOTICS Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 135. NEXTBIOTICS Recent Development
    Table 136. Armata Pharmaceuticals, Inc. Company Details
    Table 137. Armata Pharmaceuticals, Inc. Business Overview
    Table 138. Armata Pharmaceuticals, Inc. Phage Therapy Product
    Table 139. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 140. Armata Pharmaceuticals, Inc. Recent Development
    Table 141. Innophage Company Details
    Table 142. Innophage Business Overview
    Table 143. Innophage Phage Therapy Product
    Table 144. Innophage Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 145. Innophage Recent Development
    Table 146. Adaptive Phage Therapeutics Company Details
    Table 147. Adaptive Phage Therapeutics Business Overview
    Table 148. Adaptive Phage Therapeutics Phage Therapy Product
    Table 149. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 150. Adaptive Phage Therapeutics Recent Development
    Table 151. TechnoPhage Company Details
    Table 152. TechnoPhage Business Overview
    Table 153. TechnoPhage Phage Therapy Product
    Table 154. TechnoPhage Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
    Table 155. TechnoPhage Recent Development
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Phage Therapy Product Picture
    Figure 2. Global Phage Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Phage Therapy Market Size 2018-2029 (US$ Million)
    Figure 4. India Phage Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Phage Therapy Market Size 2018-2029 (US$ Million)
    Figure 6. India Phage Therapy Market Share in Global 2018-2029
    Figure 7. Phage Therapy Report Years Considered
    Figure 8. Product Picture of DsDNA Bacteriophage
    Figure 9. Product Picture of SsDNA Bacteriophage
    Figure 10. Product Picture of SsRNA Bacteriophage
    Figure 11. Product Picture of Others
    Figure 12. Global Phage Therapy Market Share by Type in 2022 & 2029
    Figure 13. Global Phage Therapy Market Size by Type (2018-2029) & (US$ Million)
    Figure 14. Global Phage Therapy Market Share by Type (2018-2029)
    Figure 15. India Phage Therapy Market Share by Type in 2022 & 2029
    Figure 16. India Phage Therapy Market Size by Type (2018-2029) & (US$ Million)
    Figure 17. India Phage Therapy Market Share by Type (2018-2029)
    Figure 18. Product Picture of Animal Health
    Figure 19. Product Picture of Aquaculture
    Figure 20. Product Picture of Agriculture
    Figure 21. Product Picture of Food Industry
    Figure 22. Product Picture of Human Health
    Figure 23. Product Picture of Others
    Figure 24. Global Phage Therapy Market Share by Application in 2022 & 2029
    Figure 25. Global Phage Therapy Market Size by Application (2018-2029) & (US$ Million)
    Figure 26. Global Phage Therapy Market Share by Application (2018-2029)
    Figure 27. India Phage Therapy Market Share by Application in 2022 & 2029
    Figure 28. India Phage Therapy Market Size by Application (2018-2029) & (US$ Million)
    Figure 29. India Phage Therapy Market Share by Application (2018-2029)
    Figure 30. The Top 5 and 10 Largest Companies of Phage Therapy in the World: Market Share by Phage Therapy Revenue in 2022
    Figure 31. Global Phage Therapy Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 32. Global Phage Therapy Market Share by Region (2018-2029)
    Figure 33. Americas Phage Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 34. Americas Phage Therapy Market Share by Type (2018-2029)
    Figure 35. Americas Phage Therapy Market Share by Application (2018-2029)
    Figure 36. United States Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Canada Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Mexico Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Brazil Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. EMEA Phage Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 41. EMEA Phage Therapy Market Share by Type (2018-2029)
    Figure 42. EMEA Phage Therapy Market Share by Application (2018-2029)
    Figure 43. Europe Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Middle East Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Africa Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 46. China Phage Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 47. China Phage Therapy Market Share by Type (2018-2029)
    Figure 48. China Phage Therapy Market Share by Application (2018-2029)
    Figure 49. APAC Phage Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 50. APAC Phage Therapy Market Share by Type (2018-2029)
    Figure 51. APAC Phage Therapy Market Share by Application (2018-2029)
    Figure 52. Japan Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. South Korea Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. China Taiwan Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Southeast Asia Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 56. India Phage Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 57. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 58. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 59. Phagelux Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 60. Intralytix Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 61. Micreos Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 62. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 63. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 64. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 65. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 66. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 67. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 68. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 69. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 70. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 71. MicroMir Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 72. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 73. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 74. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 75. Innophage Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 76. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 77. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2018-2023)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS